ORASURE TECHNOLOGIES, INC Available-for-sale Securities, Amortized Cost Basis
ORASURE TECHNOLOGIES, INC (OSUR) had Available-for-sale Securities, Amortized Cost Basis of $67.95 million as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2021-11-04
- 2021-09-30: Available-for-sale Securities, Amortized Cost Basis $67.95M.
- 2021-06-30: Available-for-sale Securities, Amortized Cost Basis $71.77M.
- 2021-03-31: Available-for-sale Securities, Amortized Cost Basis $63.11M.
- 2020-12-31: Available-for-sale Securities, Amortized Cost Basis $96.67M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2021-09-30 | $67.95M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $71.77M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $63.11M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $96.67M 10-Q · filed 2021-11-04 |
| 2020-09-30 | $100.83M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $91.65M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $93.36M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $114.16M 10-K · filed 2021-03-01 |
| 2019-09-30 | $115.82M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $114.23M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $114.48M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $113.80M 10-K · filed 2020-03-02 |
| 2018-09-30 | $114.89M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $110.97M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $115.39M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $104.27M 10-K · filed 2019-02-28 |
| 2017-09-30 | $101.96M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $55.41M 10-Q · filed 2017-08-09 |
| 2016-12-31 | $11.16M 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |